Acute Lymphoblastic Leukemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Conditions: B-Cell Non Hodgkin Lymphoma; B-Cell Acute Lymphoblastic Leukemia Intervention: Biological: anti-CD19 CAR T-cells Sponsors: Vinmec Research Institute of Stem Cell and Gene Technology; National Institute of Hematology and Blood Transfusion, Vietnam Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL)
Condition: B-cell Acute Lymphoblastic Leukemia Interventions: Biological: HY004; Drug: Cyclophosphamide; Drug: Fludarabine Phosphate Sponsor: Juventas Cell Therapy Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials
